Notices of Compliance, 2017
1,387 notices issued in 2017, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| December 29, 2017 | APO-DEFERASIROX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 29, 2017 | LUPIN-CEPHALEXIN | Lupin Pharma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| December 29, 2017 | CREDELIO | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| December 28, 2017 | ALENDRONATE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 28, 2017 | RIVA-BISOPROLOL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 28, 2017 | M-VENLAFAXINE XR | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 28, 2017 | ENALAPRIL MALEATE/HCTZ | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| December 28, 2017 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 28, 2017 | MYLAN-NIFEDIPINE EXTENDED RELEASE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2017 | M-ATORVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 27, 2017 | CONRAY 30; CONRAY 43; CONRAY 60 | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 27, 2017 | APO-LAMOTRIGINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 27, 2017 | CYSTO-CONRAY II | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2017 | XIIDRA | Shire Pharma Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 22, 2017 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2017 | MONTELUKAST | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 22, 2017 | BUPIVACAINE INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2017 | AMINOSYN | Icu Medical Canada Inc | New Drug Submission (NDS) · Labelling Only |
| December 22, 2017 | AMINOSYN II | Icu Medical Canada Inc | New Drug Submission (NDS) · Labelling Only |
| December 22, 2017 | TARO-DIPYRIDAMOLE/ASA | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 22, 2017 | GPC-SOLIFENACIN | Generic Partners (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 22, 2017 | ONSIOR | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2017 | ONSIOR | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2017 | ONSIOR | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2017 | MICOTIL | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| December 22, 2017 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2017 | TRULICITY | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2017 | DYSPORT THERAPEUTIC | Ipsen Biopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2017 | SANDOZ ZOPICLONE TABLET | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2017 | MINT-FUROSEMIDE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2017 | KETOROLAC TROMETHAMINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2017 | NOVOLIN GE 30/70; NOVOLIN GE NPH; NOVOLIN GE TORONTO | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2017 | ZOLADEX; ZOLADEX LA | Tersera Therapeutics Llc | New Drug Submission (NDS) · Labelling Only |
| December 21, 2017 | KETAMINE HYDROCHLORIDE INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 21, 2017 | APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 20, 2017 | LINEZOLID INTRAVENOUS INJECTION | Mda Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 20, 2017 | HEPAGAM B | Saol Therapeutics Research Limited | New Drug Submission (NDS) · Admin |
| December 19, 2017 | TEVA-CLOBETASOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| December 19, 2017 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2017 | APO-CARVEDILOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2017 | DESMOPRESSIN | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 19, 2017 | TEVA-LEVOFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2017 | PERIOGARD ALCOHOL FREE | Colgate-Palmolive Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2017 | VARIZIG | Saol Therapeutics Research Limited | New Drug Submission (NDS) · Admin |
| December 19, 2017 | ENBREL | Immunex Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 18, 2017 | REDDY-PROGESTERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 18, 2017 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 15, 2017 | MIFEGYMISO | Linepharma International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2017 | PANTOPRAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2017 | TRAMADOL | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 15, 2017 | GASTROGRAFIN | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2017 | APO-PANTOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2017 | KALETRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2017 | KANUMA | Alexion Pharma Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 15, 2017 | TOVIAZ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2017 | PAYLEAN 100 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| December 14, 2017 | SOLIFENACIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 13, 2017 | PERGOVERIS | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2017 | DIPYRIDAMOLE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2017 | QUETIAPINE XR | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 13, 2017 | TOPIRAMATE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 13, 2017 | TEVA-DOXYCYCLINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2017 | SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE; SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE HD; SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE LD | Sandoz Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| December 12, 2017 | METROGEL | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2017 | XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2017 | MOXIFLOXACIN INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 12, 2017 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2017 | TRIAMCINOLONE HEXACETONIDE INJECTABLE SUSPENSION | Medexus Inc | New Drug Submission (NDS) · Other |
| December 12, 2017 | AURO-CEPHALEXIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 11, 2017 | AIVLOSIN WATER SOLUBLE GRANULES | Eco Animal Health Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2017 | TEVA-LISINOPRIL (TYPE Z) | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 11, 2017 | TEVA-CEFADROXIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2017 | CIPRO; CIPRO ORAL SUSPENSION | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2017 | CIPRO XL | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 11, 2017 | BUPIVACAINE HEAVY INJECTION BP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 8, 2017 | AVELOX; AVELOX I.V. | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2017 | YTTRIGA | Eckert & Ziegler Radiopharma Gmbh | Abbreviated New Drug Submission (ANDS) · Other |
| December 8, 2017 | PULMOTIL AC | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| December 8, 2017 | PAYLEAN 20 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| December 8, 2017 | DONEPEZIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 8, 2017 | CLOZAPINE TABLETS | Therapeutic Products Inc | New Drug Submission (NDS) · Admin |
| December 8, 2017 | PHEBURANE | Medunik Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2017 | PMS-RISEDRONATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2017 | ROTATEQ | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2017 | GENTAMICIN INJECTION USP | Teligent Ou | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2017 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2017 | RISPERDAL CONSTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2017 | SANDOZ PERINDOPRIL ERBUMINE | Sandoz Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| December 7, 2017 | LEVETIRACETAM | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 7, 2017 | APO-ETIDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2017 | ACH-CAPECITABINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2017 | DATSCAN | Ge Healthcare Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 7, 2017 | BENLYSTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2017 | FOQUEST | Purdue Pharma | New Drug Submission (NDS) · Other |
| December 6, 2017 | MYLAN-IMATINIB | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2017 | APO-NORFLOX | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 4, 2017 | KETOROLAC TROMETHAMINE INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 4, 2017 | TELMISARTAN HCTZ | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 1, 2017 | RENFLEXIS | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| December 1, 2017 | DICETEL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2017 | DEPO-PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2017 | IRINOTECAN FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2017 | TICLOPIDINE | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| December 1, 2017 | ABILIFY | Otsuka Pharmaceutical Co Ltd | New Drug Submission (NDS) · Labelling Only |
| November 30, 2017 | MONTEBAN 100 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 30, 2017 | MONTEBAN 70 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 30, 2017 | OPTAFLEXX 100 | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 30, 2017 | VALACYCLOVIR | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 30, 2017 | MEROPENEM FOR INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2017 | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2017 | MDK-NITISINONE | Mendelikabs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2017 | AURO-METRONIDAZOLE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 30, 2017 | DUPIXENT | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 30, 2017 | MAVENCLAD | Emd Serono A Division Of Emd Inc Canada | New Drug Submission (NDS) · Other |
| November 29, 2017 | PRO-PIOGLITAZONE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| November 29, 2017 | NABUMETONE | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 29, 2017 | REBINYN | Novo Nordisk Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 28, 2017 | TOPOTECAN FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2017 | APO-NORTRIPTYLINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2017 | SANDOZ TAMSULOSIN CR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2017 | SANDOZ TAMSULOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2017 | TEVA-CIPROFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2017 | HUMALOG | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 27, 2017 | NORVIR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 27, 2017 | XYREM | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · Admin |
| November 27, 2017 | AURO-AMOXICILLIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 27, 2017 | SITAVIG | Cipher Pharmaceuticals Inc. | New Drug Submission (NDS) · Other |
| November 27, 2017 | TOBRADEX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 27, 2017 | MYLAN-ATORVASTATIN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2017 | GLEEVEC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2017 | MINT-ZOLMITRIPTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2017 | TEVA-FUROSEMIDE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2017 | MILRINONE LACTATE INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 24, 2017 | SANDOZ LEVETIRACETAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2017 | REYATAZ | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2017 | DRY-CLOX | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2017 | PHARMA-SIMVASTATIN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 23, 2017 | LARTRUVO | Eli Lilly Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 23, 2017 | BIODESTROY | Sani-Marc Inc | New Drug Submission (NDS) · Other |
| November 22, 2017 | ENABLEX | Merus Labs Luxco S. A R.L. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2017 | MAR-SIMVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 22, 2017 | MAR-TRAMADOL/ACET | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 22, 2017 | BACKUP PLAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2017 | TEVA-PROFEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| November 22, 2017 | JENCYCLA | Lupin Pharma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| November 22, 2017 | TEVA-ATENOLOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| November 22, 2017 | IOPIDINE | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| November 21, 2017 | KEXXTONE | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 21, 2017 | INFLACAM INJECTION | Chanelle Pharmaceuticals Manufacturing Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| November 21, 2017 | CEFTIOFUR SODIUM FOR INJECTION | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2017 | TEVA-FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2017 | METHOTREXATE INJECTION USP; METHOTREXATE INJECTION USP (WITH PRESERVATIVE) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2017 | ITRAFUNGOL | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 21, 2017 | TEVA-SILDENAFIL R | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 20, 2017 | MYFORTIC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2017 | AFINITOR DISPERZ | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2017 | PEDIAPHARM NAPROXEN SUSPENSION | Pediapharm Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2017 | APO-LORATADINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2017 | AURO-LEVOFLOXACIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2017 | ISOVUE 200 INJECTION; ISOVUE 300 INJECTION; ISOVUE 370 INJECTION; ISOVUE MULTIPACK 300; ISOVUE MULTIPACK 370 | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2017 | TEVA-RABEPRAZOLE EC | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2017 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2017 | VICTOZA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2017 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2017 | CUBICIN RF | Cubist Pharmaceuticals Llc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2017 | ADMELOG | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Other |
| November 15, 2017 | RAN-TRAMADOL/ACET | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2017 | PHARMA-AMLODIPINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 15, 2017 | GLN-OLMESARTAN | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2017 | ORFADIN | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2017 | MINT-TRAMADOL/ACET | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 14, 2017 | MOCLOBEMIDE | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 14, 2017 | AURO-CLINDAMYCIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2017 | FLUDEOXYGLUCOSE F18 INJECTION | Montreal Neurological Institute | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2017 | ADACEL-POLIO | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2017 | MAXIBAN PREMIX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 10, 2017 | TREMFYA | Janssen Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 10, 2017 | MYLAN-CINACALCET | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2017 | APO-CLINDAMYCIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2017 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2017 | ACID REDUCER | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2017 | LETROZOLE TABLETS | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2017 | NIASTASE RT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2017 | ROCURONIUM BROMIDE INJECTION | Mda Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 10, 2017 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2017 | PACLITAXEL INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2017 | INNOHEP | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2017 | PANTOPRAZOLE SODIUM FOR INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2017 | TEVA-MOXIFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2017 | APO-METHYLPHENIDATE ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2017 | APO-FLECAINIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 9, 2017 | TEVA-LANSOPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2017 | PULMICORT TURBUHALER | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2017 | CESAMET | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2017 | APO-LETROZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2017 | TEVA-LETROZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2017 | CISATRACURIUM BESYLATE INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 8, 2017 | APO-FROVATRIPTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2017 | SANDOZ TIMOLOL | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 8, 2017 | TRAMADOL/ACET | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| November 8, 2017 | APO-EMTRICITABINE-TENOFOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2017 | FASLODEX | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2017 | SERTRALINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| November 7, 2017 | ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 7, 2017 | INFLECTRA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2017 | APO-PINAVERIUM | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 7, 2017 | VETMEDIN 1.25 MG CHEWABLE TABLETS; VETMEDIN 10 MG CHEWABLE TABLETS; VETMEDIN 2.5 MG CHEWABLE TABLETS; VETMEDIN 5 MG CHEWABLE TABLETS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2017 | MIFEGYMISO | Linepharma International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 6, 2017 | SANDOZ QUETIAPINE XRT | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 6, 2017 | MINT-BISOPROLOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 6, 2017 | ANTHRASIL (ANTHRAX IMMUNE GLOBULIN (HUMAN)) | Emergent Biosolutions Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 6, 2017 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 5, 2017 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2017 | IMFINZI | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 3, 2017 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2017 | OLANZAPINE ODT | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| November 3, 2017 | RAMIPRIL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 3, 2017 | KETOROLAC TROMETHAMINE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 3, 2017 | DILANTIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2017 | HALAVEN | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2017 | SANDOZ ANASTROZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2017 | ABILIFY MAINTENA | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2017 | CARNITOR | Leadiant Biosciences, Inc. | New Drug Submission (NDS) · Labelling Only |
| November 2, 2017 | HYDROMORPHONE HP 10; HYDROMORPHONE HP 20; HYDROMORPHONE HP 50; HYDROMORPHONE HP FORTE INJECTION; HYDROMORPHONE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2017 | ETHACRYNATE SODIUM FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 2, 2017 | CONSTELLA | Forest Laboratories Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2017 | REVALOR-XR | Intervet Canada Corp | New Drug Submission (NDS) · Other |
| November 1, 2017 | IMRESTOR | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 1, 2017 | FLUKIVER | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| November 1, 2017 | PREVYMIS | Merck Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| November 1, 2017 | BACA RESPICLICK | Teva Canada Limited | New Drug Submission (NDS) · Other |
| November 1, 2017 | OPTIRAY 240; OPTIRAY 240 ULTRAJECT; OPTIRAY 300; OPTIRAY 300 ULTRAJECT; OPTIRAY 320; OPTIRAY 320 ULTRAJECT; OPTIRAY 350; OPTIRAY 350 ULTRAJECT | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2017 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2017 | NEUPRO | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2017 | HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10; HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50; HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2017 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Alveda Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2017 | CEFAZOLIN FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2017 | PRINIVIL | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2017 | SANDOZ RISPERIDONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2017 | MED-DORZOLAMIDE-TIMOLOL | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 30, 2017 | ZEVTERA | Avir Pharma Inc | New Drug Submission (NDS) · Admin |
| October 30, 2017 | CUVPOSA | Pediapharm Inc | New Drug Submission (NDS) · Other |
| October 30, 2017 | PMS-BENZYDAMINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 30, 2017 | PRAMIPEXOLE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| October 30, 2017 | ZOPICLONE | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| October 27, 2017 | DESLORATADINE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2017 | TELEBRIX 38 ORAL | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2017 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Priority |
| October 27, 2017 | AURO-EZETIMIBE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 27, 2017 | AURO-DUTASTERIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 26, 2017 | ADYNOVATE | Baxalta Canada Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2017 | LINEZOLID INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 26, 2017 | MYLAN-BUPRENORPHINE/NALOXONE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2017 | MIDAZOLAM INJECTION USP (WITH PRESERVATIVE); MIDAZOLAM INJECTION USP (WITHOUT PRESERVATIVE) | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 25, 2017 | PHARMA-ESCITALOPRAM | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 25, 2017 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| October 25, 2017 | PRID DELTA | Ceva Animal Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2017 | IMAVEROL | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| October 25, 2017 | BOVIMECTIN | Alberta Veterinary Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Admin |
| October 25, 2017 | COBAN PREMIX | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| October 25, 2017 | CLINACOX 0.5% | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| October 25, 2017 | REVALOR-XH | Intervet Canada Corp | New Drug Submission (NDS) · Other |
| October 25, 2017 | PANTOPRAZOLE | Altamed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| October 24, 2017 | GEMCITABINE FOR INJECTION, USP | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2017 | AZACITIDINE FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2017 | REDDY-AZACITIDINE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2017 | AZACITIDINE FOR INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2017 | TISSEEL | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 24, 2017 | ARTISS | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2017 | TEVA-MIRTAZAPINE OD | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 23, 2017 | LUPIN-CEPHALEXIN | Lupin Pharma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 23, 2017 | ZUPREVO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| October 23, 2017 | AMIGLYDE-V | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2017 | NIASPAN FCT | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2017 | ZYKADIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2017 | APO-SELEGILINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2017 | PIMOZIDE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2017 | VARITHENA | Provensis Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | PRAVACHOL | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | INVEGA SUSTENNA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | ZITHROMAX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | PHEBURANE | Medunik Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | KUVAN | Biomarin Pharmaceutical Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | APIDRA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | LANTUS | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | CORTIPRO SPRAY | Nor Vet Sales Inc | New Drug Submission (NDS) · Admin |
| October 19, 2017 | BENZOYLPRO-3 | Nor Vet Sales Inc | New Drug Submission (NDS) · Admin |
| October 19, 2017 | MICODERM | Nor Vet Sales Inc | New Drug Submission (NDS) · Admin |
| October 19, 2017 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2017 | GLEPTOSIL | Ceva Animal Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2017 | TAMIFLU | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2017 | TEVA-ESCITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2017 | MINT-ACITRETIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 18, 2017 | FERTILINE | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2017 | PHARMA-RAMIPRIL | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 17, 2017 | OMEPRAZOLE-20 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 17, 2017 | EMEND IV | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 16, 2017 | MED-LATANOPROST | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2017 | APO-AMLODIPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2017 | BORTEZOMIB FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 16, 2017 | NORVIR | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2017 | GABAPENTIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 13, 2017 | REVESTIVE | Shire Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2017 | SHINGRIX | Glaxosmithkline Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 13, 2017 | MELPHALAN FOR INJECTION | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 13, 2017 | ACH-OLMESARTAN HCTZ | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 12, 2017 | FLUOROURACIL INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| October 11, 2017 | TRIUMEQ | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2017 | AURO-MOXIFLOXACIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2017 | ACT CIPROFLOXACIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 11, 2017 | IPG-TRAMADOL/ACET | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2017 | TEVA-ERLOTINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2017 | ACCEL-SEVELAMER | Accel Pharma Inc | New Drug Submission (NDS) · Other |
| October 11, 2017 | AURO-CEFIXIME | Auro Pharma Inc. | New Drug Submission (NDS) · Other |
| October 10, 2017 | PRO-OTIC HC | Nor Vet Sales Inc | New Drug Submission (NDS) · Admin |
| October 10, 2017 | RIVA-CLINDAMYCIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 10, 2017 | FIBRYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2017 | IPG-SIMVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 10, 2017 | NEXIUM | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2017 | FRAGMIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 10, 2017 | PREGABALIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 10, 2017 | RIZATRIPTAN ODT | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 6, 2017 | PMS-VORICONAZOLE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 6, 2017 | APO-TEMOZOLOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2017 | KALETRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 6, 2017 | DIPROSALIC | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2017 | TEVA-MODAFINIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| October 5, 2017 | HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 5, 2017 | INOMAX | Ino Therapeutics | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2017 | AVANDIA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2017 | TEVA-DOXYLAMINE/PYRIDOXINE DR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 5, 2017 | GRASTOFIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2017 | TRUMENBA | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 4, 2017 | APO-KETOROLAC | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| October 4, 2017 | APO-HYDROXYUREA | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2017 | DIAZEPAM INJECTION USP | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2017 | PANZYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2017 | ELOCTATE | Bioverativ Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2017 | APO-DESVENLAFAXINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 3, 2017 | HYDROCORTISONE SPRAY | Inland Veterinary Supply Ltd | New Drug Submission (NDS) · Admin |
| October 2, 2017 | PAMIDRONATE DISODIUM FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 2, 2017 | MINT-HYDRALAZINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 2, 2017 | BENZOYL PEROXIDE SHAMPOO | Inland Veterinary Supply Ltd | New Drug Submission (NDS) · Admin |
| October 2, 2017 | MICONAZOLE SHAMPOO | Inland Veterinary Supply Ltd | New Drug Submission (NDS) · Admin |
| October 2, 2017 | HYDROCORTISONE DROPS | Inland Veterinary Supply Ltd | New Drug Submission (NDS) · Admin |
| September 29, 2017 | TEVA-ALMOTRIPTAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2017 | T-LO; TIMOLOL MALEATE-EX | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2017 | ACT AMLODIPINE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2017 | ULTRAVIST 300; ULTRAVIST 370 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2017 | ACT CIPROFLOXACIN | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2017 | PROPOFOL | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| September 28, 2017 | ZOLEDRONIC ACID FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 28, 2017 | APO-LISINOPRIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2017 | XENICAL | Cheplapharm Arzneimittel Gmbh Germany | New Drug Submission (NDS) · Labelling Only |
| September 28, 2017 | AKYNZEO | Purdue Pharma | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 28, 2017 | ROTATEQ | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2017 | CETROTIDE | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| September 27, 2017 | ALFAXAN MULTIDOSE | Jurox Pty Limited | New Drug Submission (NDS) · Other |
| September 26, 2017 | ATOMOXETINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| September 26, 2017 | ABSTRAL | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2017 | SANDOZ PRAVASTATIN TABLETS | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 26, 2017 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2017 | MONISTAT 3 VAGINAL CREAM; MONISTAT 7 VAGINAL CREAM; MONISTAT DERM CREAM | Insight Pharmaceuticals LLC | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2017 | TEPADINA | Adienne Sa | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2017 | FENTANYL CITRATE INJECTION USP | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Admin |
| September 25, 2017 | TOUJEO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 25, 2017 | BERIPLEX P/N 1000; BERIPLEX P/N 500 | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2017 | RETIN-A | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2017 | SYNAREL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2017 | PRZ-SILDENAFIL | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 22, 2017 | BOSENTAN | Panda Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 22, 2017 | JAMP-ESCITALOPRAM | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| September 22, 2017 | PREMARIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2017 | APO-DORZO-TIMOP | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 21, 2017 | ACT LISINOPRIL | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2017 | ARCOSYL PLUS; ARCOSYL PLUS LD | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2017 | MEFLOQUINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2017 | LANVIS | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2017 | SYNFLORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2017 | PRAVASTATIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 20, 2017 | ACT RANITIDINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2017 | RATIO-CEFUROXIME | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| September 20, 2017 | LMD 10% IN DEXTROSE 5% | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| September 20, 2017 | LMD 10% IN 0.9% SODIUM CHLORIDE | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| September 20, 2017 | TEVA-LEFLUNOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2017 | THROMBATE III | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2017 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| September 19, 2017 | NUBAIN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2017 | BICNU | Marcan Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| September 19, 2017 | JAMP-DOMPERIDONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| September 19, 2017 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 19, 2017 | ALENDRONATE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 19, 2017 | TOBRAMYCIN INHALATION SOLUTION USP | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 19, 2017 | DOBUTAMINE INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| September 18, 2017 | CIPROFLOXACIN INJECTION USP; CIPROFLOXACIN INTRAVENOUS INFUSION BP; SANDOZ CIPROFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2017 | ARCOSYL | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2017 | STIVARGA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| September 18, 2017 | ACT METHYLPHENIDATE ER | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 18, 2017 | ACT METHYLPHENIDATE ER | Actavis Pharma Company | Abbreviated New Drug Submission (ANDS) · Other |
| September 18, 2017 | WINRHO SDF | Aptevo Biotherapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| September 18, 2017 | BERINERT 1500; BERINERT 500 | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2017 | JAMP-ZOPICLONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| September 15, 2017 | ACT BUPRENORPHINE/NALOXONE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2017 | SANDOZ LEVOFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2017 | APO-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2017 | METHACHOLINE CHLORIDE, USP | Panda Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| September 15, 2017 | CLASTEON | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2017 | INTERCEPTOR PLUS | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| September 15, 2017 | THYRO-TABS CANINE | Lloyd Inc. Of Iowa | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2017 | RITUXAN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2017 | HUMATE-P | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2017 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2017 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2017 | SANDOZ MOXIFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2017 | TEVA-5 ASA | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2017 | APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 14, 2017 | EPCLUSA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2017 | PNEUMOVAX 23 | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2017 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2017 | MELOXIDYL 20 MG/ML | Ceva Animal Health Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 12, 2017 | BERINERT 1500; BERINERT 500 | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2017 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2017 | CUBICIN RF | Cubist Pharmaceuticals Llc | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2017 | DYMISTA | BGP Pharma ULC | New Drug Submission (NDS) · Labelling Only |
| September 12, 2017 | CYTARABINE INJECTION | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| September 12, 2017 | TARO-PHENYTOIN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 12, 2017 | ACH-TOLTERODINE TARTRATE EXTENDED RELEASE | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 12, 2017 | SANDOZ SOLIFENACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 11, 2017 | BUSCOPAN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2017 | QUINSAIR | Horizon Pharma Ireland Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 11, 2017 | CLOZARIL | Hls Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2017 | PRV-RAMIPRIL | Pharmapar Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 8, 2017 | ACT ESOMEPRAZOLE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 8, 2017 | FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2017 | FLUZONE HIGH-DOSE | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2017 | MYLAN-ALENDRONATE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2017 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2017 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2017 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2017 | JEVTANA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2017 | FERROFORTE | Bimeda-MTC Animal Health Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 7, 2017 | MARCAINE; MARCAINE SPINAL | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| September 7, 2017 | MARCAINE E | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| September 7, 2017 | MAR-ZOPICLONE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 7, 2017 | LORAZEPAM INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 7, 2017 | ACT MELOXICAM | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| September 7, 2017 | METFORMIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 7, 2017 | BELBUCA | Purdue Pharma | New Drug Submission (NDS) · Admin |
| September 7, 2017 | APO-LATANOPROST | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 7, 2017 | MAR-METFORMIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 7, 2017 | METRONIDAZOLE INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| September 6, 2017 | RIVA-ALENDRONATE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 6, 2017 | PMS-CIPROFLOXACIN XL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2017 | MINT-OLOPATADINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 5, 2017 | AZITHROMYCIN FOR INJECTION, USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 5, 2017 | GALAFOLD | Amicus Therapeutics Uk Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| September 5, 2017 | INFLUVAC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 5, 2017 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 1, 2017 | PMS-PROPOFOL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2017 | SANDOZ QUETIAPINE XRT | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 1, 2017 | TEVA-METOPROLOL; TEVA-METOPROLOL (FILM COATED) | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2017 | SUBOXONE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2017 | RIASTAP | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2017 | HAEGARDA | Csl Behring Canada Inc | New Drug Submission (NDS) · Other |
| August 31, 2017 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2017 | AGRIFLU; AGRIFLU (MULTI DOSE VIAL) | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2017 | LANSOPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 31, 2017 | M-ZOPICLONE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 31, 2017 | METHOTREXATE SODIUM INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2017 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 31, 2017 | LANSOPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 31, 2017 | M-AMLODIPINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 31, 2017 | GEMCITABINE INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 31, 2017 | APO-FLUTICASONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 31, 2017 | PDP-AMANTADINE HYDROCHLORIDE CAPSULES | Pendopharm Division Of De Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2017 | EPREX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2017 | DALACIN C FLAVOURED GRANULES | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2017 | ULTIBRO BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2017 | APO-GEFITINIB | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 30, 2017 | ATOMOXETINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| August 30, 2017 | ACT LEVOFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2017 | AURO-RAMIPRIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2017 | PMS-ERLOTINIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2017 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2017 | TEVA-PRAZOSIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2017 | STIVARGA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 29, 2017 | NAT-BOSENTAN | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2017 | REOPRO | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2017 | BRENZYS | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2017 | APO-EPLERENONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 28, 2017 | XALKORI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 28, 2017 | GD-EPLERENONE | Genmed A Division Of Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 25, 2017 | TEVA-LEVOFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2017 | APO-METHOTREXATE | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 25, 2017 | PMS-BUPRENORPHINE-NALOXONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 25, 2017 | TARCEVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2017 | WOMEN'S ROGAINE FOAM 5% | Johnson & Johnson Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2017 | TRESIBA (FLEXTOUCH); TRESIBA (PENFILL) | Novo Nordisk Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 25, 2017 | LEUKERAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2017 | ALEVE; ALEVE LIQUID GELS | Bayer Inc Consumer Care | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2017 | ALEVE BACK AND BODY | Bayer Inc Consumer Care | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2017 | ATOMOXETINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 24, 2017 | TELEBRIX 38 ORAL | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2017 | AZITHROMYCIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 24, 2017 | ATORVASTATIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 24, 2017 | M-ATORVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 24, 2017 | M-CITALOPRAM | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 24, 2017 | ACT DILTIAZEM CD | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| August 24, 2017 | BRENZYS (PFP); BRENZYS (PFS) | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2017 | GLUCOPHAGE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2017 | XGEVA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2017 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2017 | RAN-METFORMIN | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2017 | OMNIPAQUE | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2017 | VISIPAQUE | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2017 | CYSTO-CONRAY II | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2017 | CONRAY 30; CONRAY 43; CONRAY 60 | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2017 | GASTROGRAFIN | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2017 | PMS-ALENDRONATE; PMS-ALENDRONATE-FC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 22, 2017 | AERMONY RESPICLICK | Teva Canada Limited | New Drug Submission (NDS) · Other |
| August 22, 2017 | ACTIVASE RT-PA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2017 | CATHFLO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2017 | TNKASE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2017 | ADVIL HEADACHE & MIGRAINE CAPLETS; ADVIL HEADACHE & MIGRAINE EXTRA STRENGTH; ADVIL HEADACHE & MIGRAINE TABLETS | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | New Drug Submission (NDS) · Labelling Only |
| August 22, 2017 | ADVIL MIGRAINE CAPLETS; ADVIL MIGRAINE EXTRA STRENGTH; ADVIL MIGRAINE TABLETS | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | New Drug Submission (NDS) · Labelling Only |
| August 22, 2017 | ADVIL HEADACHE CAPLETS; ADVIL HEADACHE EXTRA STRENGTH; ADVIL HEADACHE TABLETS | Pfizer Consumer Healthcare, a division of Pfizer Canada ULC | New Drug Submission (NDS) · Labelling Only |
| August 21, 2017 | ARANESP | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2017 | ESTRADOT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 21, 2017 | ESTALIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2017 | CAELYX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2017 | M-ESCITALOPRAM | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2017 | M-EZETIMIBE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2017 | M-PANTOPRAZOLE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2017 | M-PAROXETINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2017 | M-PRAVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2017 | ACT ENALAPRIL | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| August 18, 2017 | REACTINE RAPID DISSOLVE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | New Drug Submission (NDS) · Labelling Only |
| August 18, 2017 | DESLORATADINE ALLERGY CONTROL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2017 | ELELYSO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2017 | MYLAN-BUPRENORPHINE/NALOXONE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2017 | M-PREGABALIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2017 | DOM-GABAPENTIN | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 17, 2017 | DONEPEZIL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2017 | RIVA-MIRTAZAPINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 17, 2017 | M-DONEPEZIL | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2017 | JAMP-ENTECAVIR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2017 | METHOTREXATE TABLETS, USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 17, 2017 | M-ROSUVASTATIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2017 | CHLORHEXIDINE GLUCONATE ORAL RINSE | Colgate-Palmolive Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 17, 2017 | APO-CEFEPIME | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| August 17, 2017 | ZOLEDRONIC ACID FOR INJECTION CONCENTRATE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2017 | VANQUISH PRE POST TEAT DIP (ACTIVATOR OR BASE) | DeLaval, Inc. | New Drug Submission (NDS) · Other |
| August 17, 2017 | FLEBOGAMMA 10%; FLEBOGAMMA 5% | Instituto Grifols S.A. | New Drug Submission (NDS) · Other |
| August 16, 2017 | VINBLASTINE SULFATE INJECTION | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 16, 2017 | ACT LEVOFLOXACIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| August 16, 2017 | VOSEVI | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| August 16, 2017 | MAVIRET | AbbVie Corporation | New Drug Submission (NDS) · Priority-NAS |
| August 16, 2017 | VARILRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2017 | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 15, 2017 | SENSORCAINE; SENSORCAINE WITH EPINEPHRINE | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| August 15, 2017 | XYLOCARD | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| August 14, 2017 | OCREVUS | Hoffmann-La Roche Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 14, 2017 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | Panda Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 14, 2017 | MYLAN-CIPROFLOXACIN | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 14, 2017 | RAN-CIPROFLOX | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2017 | PRIORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2017 | PACLITAXEL FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 11, 2017 | MIDAZOLAM INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2017 | NEUPRO | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2017 | PRIORIX-TETRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2017 | VARILRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2017 | ACYCLOVIR SODIUM INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 10, 2017 | MATULANE | Leadiant Biosciences, Inc. | New Drug Submission (NDS) · Admin |
| August 9, 2017 | OTIXAL | Pediapharm Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2017 | ACT PANTOPRAZOLE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2017 | ONIVYDE | Baxalta Canada Corporation | New Drug Submission (NDS) · Priority |
| August 9, 2017 | BORTEZOMIB FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2017 | APO-DESVENLAFAXINE | Apotex Inc. | New Drug Submission (NDS) · Other |
| August 8, 2017 | MODECATE CONCENTRATE | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2017 | FLUDEOXYGLUCOSE (F-18) | Thunder Bay Regional Health Sciences Centre | Abbreviated New Drug Submission (ANDS) · Other |
| August 8, 2017 | EMLA CREAM; EMLA PATCH | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| August 8, 2017 | BLEOMYCIN FOR INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 8, 2017 | TEVA-MYCOPHENOLATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 8, 2017 | ROPIVACAINE HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 8, 2017 | TOMUDEX | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 8, 2017 | DIPRIVAN 1% | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| August 4, 2017 | ALMOTRIPTAN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 4, 2017 | ANAFRANIL | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| August 4, 2017 | PRZ-DOMPERIDONE | Pharmaris Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2017 | HALAVEN | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2017 | REMICADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2017 | SIMPONI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2017 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2017 | RESTORIL | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| August 3, 2017 | BOSULIF | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 3, 2017 | ACTONEL; ACTONEL DR | Allergan Pharma Co. | New Drug Submission (NDS) · Labelling Only |
| August 2, 2017 | GD-VARENICLINE | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| August 2, 2017 | NIPRIDE | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 2, 2017 | TEVA-PRAVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2017 | SANDOZ OXCARBAZEPINE | Sandoz Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| August 2, 2017 | SANDOZ AZITHROMYCIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2017 | FUROSEMIDE INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 2, 2017 | PMS-TENOFOVIR | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 1, 2017 | EPCLUSA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 1, 2017 | LABETALOL HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 1, 2017 | RAN-CLOPIDOGREL | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 1, 2017 | LEUCOVORIN CALCIUM INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| August 1, 2017 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 31, 2017 | IPG-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 28, 2017 | RIVA-PANTOPRAZOLE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 28, 2017 | AURO-CYCLOBENZAPRINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 28, 2017 | PMS-CYCLOBENZAPRINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2017 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2017 | NAROPIN | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| July 28, 2017 | TEVA-HALOPERIDOL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2017 | APO-CYCLOBENZAPRINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2017 | HARVONI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2017 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2017 | SOVALDI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2017 | PAMIDRONATE DISODIUM FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 27, 2017 | PONSTAN | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| July 27, 2017 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2017 | ORALAIR | Stallergenes Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2017 | ENTUZITY KWIKPEN | Eli Lilly Canada Inc | New Drug Submission (NDS) · Other |
| July 26, 2017 | SANDOZ NARATRIPTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2017 | ACT BUPROPION XL | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2017 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | MYLAN-CYCLOBENZAPRINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2017 | EMEND IV | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2017 | PMS-EMTRICITABINE-TENOFOVIR | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | TEVA-TENOFOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2017 | AURO-TENOFOVIR | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | MYLAN-TENOFOVIR DISOPROXIL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | APO-TENOFOVIR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | TEVA-EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2017 | TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2017 | TEVA-EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2017 | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | TEVA-TENOFOVIR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2017 | TEVA-EMTRICITABINE/TENOFOVIR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 25, 2017 | ACT ROPINIROLE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2017 | ISOVUE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2017 | APO-CLOBAZAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2017 | CYKLOKAPRON | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2017 | CHOLOGRAFIN MEGLUMINE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2017 | SINOGRAFIN | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2017 | PMS-SALBUTAMOL | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2017 | ROCALTROL | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2017 | FLECAINIDE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 24, 2017 | TOBREX; TOBREXAN | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| July 24, 2017 | BREO ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 24, 2017 | MINT-FUROSEMIDE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 21, 2017 | BENEFIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2017 | RYDAPT | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Priority-NAS |
| July 21, 2017 | PREZISTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2017 | PMS-BORTEZOMIB | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 21, 2017 | ZOLEDRONIC ACID - Z | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 21, 2017 | JAMP-QUETIAPINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 21, 2017 | BIO-BOSENTAN | Biomed Pharma | New Drug Submission (NDS) · Admin |
| July 21, 2017 | VINORELBINE TARTRATE FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 21, 2017 | HALAVEN | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2017 | MOVANTIK | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| July 20, 2017 | GALEXOS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2017 | SINEQUAN | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| July 20, 2017 | TARO-CLARITHROMYCIN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2017 | DUAVIVE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2017 | FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2017 | FLUZONE HIGH-DOSE | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2017 | BETAHISTINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 20, 2017 | ABELCET | Leadiant Biosciences, Inc. | New Drug Submission (NDS) · Admin |
| July 20, 2017 | ATENOLOL | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| July 20, 2017 | APO-VENLAFAXINE XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2017 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2017 | LATUDA | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2017 | ADCETRIS | Seattle Genetics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2017 | FRAXIPARINE; FRAXIPARINE FORTE | Aspen Pharma Trading Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2017 | AURO-NITROFURANTOIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 18, 2017 | CONSTELLA | Forest Laboratories Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2017 | SANDOZ LATANOPROST | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2017 | SUPRAX | Odan Laboratories Ltd. | New Drug Submission (NDS) · Admin |
| July 14, 2017 | JAMP-CETIRIZINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| July 14, 2017 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2017 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2017 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2017 | LIPIODOL ULTRA FLUID | Guerbet | New Drug Submission (NDS) · Other |
| July 13, 2017 | PANTOPRAZOLE T | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 12, 2017 | AGGRASTAT | Correvio (Uk) Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2017 | NAPROXEN | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| July 12, 2017 | DEFEROXAMINE MESYLATE FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| July 12, 2017 | ESCITALOPRAM | Jubilant Generics Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 12, 2017 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2017 | SAXENDA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2017 | RIVA-PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2017 | PMS-PROPAFENONE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| July 11, 2017 | PANTOPRAZOLE-20; PANTOPRAZOLE-40 | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 11, 2017 | RIVA-RISPERIDONE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2017 | MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2017 | DESLORATADINE ALLERGY CONTROL | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| July 11, 2017 | LOLO | Allergan Pharma Co. | New Drug Submission (NDS) · Labelling Only |
| July 11, 2017 | DEXAFER-200 | Vetoquinol N A Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2017 | MACROBID | Allergan Pharma Co. | New Drug Submission (NDS) · Labelling Only |
| July 10, 2017 | DEFITELIO | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · Priority-NAS |
| July 10, 2017 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 10, 2017 | MITOMYCIN FOR INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2017 | DOCETAXEL INJECTION USP | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 10, 2017 | TARO-ACITRETIN | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 7, 2017 | PROVOCHOLINE | Methapharm Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2017 | AREPANRIX H5N1 | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2017 | EXTRA STRENGTH ALLERGY RELIEF | Dominion Pharmacal | Abbreviated New Drug Submission (ANDS) · Admin |
| July 7, 2017 | CEFTRIAXONE SODIUM FOR INJECTION BP | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Admin |
| July 7, 2017 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Admin |
| July 7, 2017 | KYPROLIS | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2017 | TRANEXAMIC ACID INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 6, 2017 | ULTRAVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2017 | RAN-ROSUVASTATIN | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 6, 2017 | CHLORHEXIDINE ALCOHOL FREE | Euro-Pharm International Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 6, 2017 | CHLORHEXIDINE | Euro-Pharm International Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 6, 2017 | SANDOZ MYCOPHENOLIC ACID | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| July 6, 2017 | FLAGYL | Odan Laboratories Ltd. | New Drug Submission (NDS) · Admin |
| July 6, 2017 | TECFIDERA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2017 | TEVA-BUDESONIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| July 6, 2017 | PMS-DOXYLAMINE-PYRIDOXINE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 5, 2017 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2017 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2017 | ZOLEDRONIC ACID - A | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 5, 2017 | LEVOTHYROXINE SODIUM FOR INJECTION | Avir Pharma Inc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 5, 2017 | ODAN-LEFLUNOMIDE | Odan Laboratories Ltd. | New Drug Submission (NDS) · Admin |
| July 4, 2017 | APO-DOXYLAMINE/B6 | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 4, 2017 | SANDOZ AZITHROMYCIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2017 | PMS-OLMESARTAN-HCTZ | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 4, 2017 | CIMZIA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2017 | NAT-VALGANCICLOVIR | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2017 | APO-CAPECITABINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2017 | PROLASTIN-C | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2017 | CYTOVENE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2017 | APO-TRAZODONE; APO-TRAZODONE D | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2017 | CUBICIN RF | Cubist Pharmaceuticals Llc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2017 | TARO-DOCETAXEL | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2017 | MINT-BISOPROLOL | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2017 | PEMETREXED FOR INJECTION | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| June 29, 2017 | PENTAMIDINE ISETIONATE FOR INJECTION BP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| June 29, 2017 | PMS-OLMESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 29, 2017 | ATROVENT NASAL SPRAY | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| June 29, 2017 | SPINRAZA | Biogen Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 28, 2017 | ULTRA-TECHNEKOW V4 | Mallinckrodt Rp Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2017 | BANAMINE | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2017 | SIMPONI; SIMPONI I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2017 | CEFAZOLIN FOR INJECTION USP | Qilu Pharmaceutical Co. Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| June 26, 2017 | TEVA-DEFERASIROX | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 26, 2017 | TARO-DEFERASIROX | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 26, 2017 | APO-DEFERASIROX | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 26, 2017 | TEVA-DEFERASIROX | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 23, 2017 | APO-FLUOXETINE | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| June 23, 2017 | EPIRUBICIN HYDROCHLORIDE INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 23, 2017 | OMNISCAN | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2017 | VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH | Glaxosmithkline Consumer Healthcare Ulc | New Drug Submission (NDS) · Labelling Only |
| June 23, 2017 | VOLTAREN EMULGEL BACK & MUSCLE PAIN | Glaxosmithkline Consumer Healthcare Ulc | New Drug Submission (NDS) · Labelling Only |
| June 22, 2017 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2017 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2017 | NPLATE | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2017 | GIOTRIF | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2017 | RIVA-LANSOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2017 | CIPROFLOXACIN INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2017 | CCP-LETROZOLE | CellChem Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2017 | VIVACAINE | Septodont | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2017 | PROPOFOL INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2017 | ISENTRESS HD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2017 | PEMETREXED DISODIUM FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2017 | MAR-DILTIAZEM T | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 21, 2017 | BELBUCA | Paladin Labs Inc | New Drug Submission (NDS) · Other |
| June 21, 2017 | MINT-FENOFIBRATE E | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 21, 2017 | ZEVALIN | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2017 | PMS-TADALAFIL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2017 | LESCOL XL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2017 | DUODOPA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2017 | RAPIVAB | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2017 | MOVANTIK | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2017 | CCP-ZOLMITRIPTAN | CellChem Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 20, 2017 | CCP-ONDANSETRON | CellChem Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2017 | ALERTEC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2017 | DOTAREM | Guerbet | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2017 | OPTIMARK | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 19, 2017 | MAPRELIN XP-10 | Modern Veterinary Therapeutics Llc | New Drug Submission (NDS) · Other |
| June 19, 2017 | CCP-ANASTROZOLE | CellChem Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 19, 2017 | CCP-RIZATRIPTAN ODT | CellChem Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2017 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| June 16, 2017 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2017 | ACT DEXTROAMPHETAMINE SR | Actavis Pharma Company | Supplement to a New Drug Submission (SNDS) · Other |
| June 16, 2017 | MAR-KETOROLAC | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 16, 2017 | TORADOL | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| June 16, 2017 | AURO-PANTOPRAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2017 | VERAPAMIL HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| June 16, 2017 | DOM-LANSOPRAZOLE | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2017 | JAMP-RIZATRIPTAN ODT | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 16, 2017 | DOCETAXEL INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| June 16, 2017 | CIPROFLOXACIN INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 16, 2017 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2017 | APO-OMEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2017 | FLUOROURACIL INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2017 | HARVONI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2017 | NEUPOGEN | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2017 | VICTOZA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2017 | RBX-CLOPIDOGREL | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2017 | SANDOZ RANITIDINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 14, 2017 | MAR-RIZATRIPTAN | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 13, 2017 | SANDOZ FINASTERIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2017 | PMS-FLUOXETINE | Pharmascience Inc. | New Drug Submission (NDS) · Other |
| June 13, 2017 | PROCYSBI | Horizon Pharma Ireland Ltd | New Drug Submission (NDS) · Priority-NAS |
| June 13, 2017 | CONVENIA | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 12, 2017 | METHOTREXATE INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 12, 2017 | STELARA; STELARA I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2017 | XERESE | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2017 | BYDUREON | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2017 | METHOTREXATE TABLETS, USP | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2017 | MYLAN-PANTOPRAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2017 | CIPROFLOXACIN INTRAVENOUS INFUSION, BP | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2017 | MITOMYCIN FOR INJECTION USP | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 8, 2017 | IPG-METFORMIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2017 | SANDOZ DEFERASIROX | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| June 8, 2017 | MYLAN-RABEPRAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2017 | SANDOZ MONTELUKAST | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2017 | IMIPENEM AND CILASTATIN FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 7, 2017 | RHINOCORT AQUA | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | New Drug Submission (NDS) · Admin |
| June 7, 2017 | KETOROLAC TROMETHAMINE INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 7, 2017 | MEROPENEM FOR INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 7, 2017 | EXTRA STRENGTH NIGHTTIME PAIN RELIEVER / SLEEP AID | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 7, 2017 | IMRESTOR | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2017 | PEROX-AID | Syndel Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2017 | FIBRYNA | Octapharma Pharmazeutika Produktionsges M B H | New Drug Submission (NDS) · Other |
| June 6, 2017 | METHOTREXATE INJECTION USP; METHOTREXATE INJECTION USP (WITH PRESERVATIVE) | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| June 6, 2017 | VALACYCLOVIR | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 6, 2017 | TEVA-ATORVASTATIN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 6, 2017 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2017 | TYLOSIN 40 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 5, 2017 | ONDANSETRON INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 5, 2017 | IGIVNEX | Grifols Therapeutics Llc | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2017 | SANDOZ ESCITALOPRAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2017 | LEVETIRACETAM | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2017 | ESBRIET | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2017 | VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2017 | OXALIPLATIN | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2017 | VINCRISTINE SULFATE INJECTION USP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| June 1, 2017 | PMS-ESOMEPRAZOLE DR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2017 | COTELLIC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2017 | VOLTAREN OPHTHA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| May 31, 2017 | ONDANSETRON | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2017 | CISPLATIN INJECTION BP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| May 31, 2017 | DACARBAZINE FOR INJECTION BP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2017 | TEVA-FOSINOPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2017 | TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 31, 2017 | PMS-PREGABALIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 30, 2017 | ARGATROBAN | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| May 30, 2017 | MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 30, 2017 | FOSAVANCE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2017 | FOSAMAX | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2017 | INFLUVAC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2017 | KEVZARA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2017 | ENBREL | Immunex Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 29, 2017 | ALOXI | Purdue Pharma | New Drug Submission (NDS) · Admin |
| May 26, 2017 | BORGAL | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2017 | SALIX | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2017 | TRIQUILAR 28 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2017 | ZEPATIER | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2017 | DAKLINZA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 26, 2017 | TEVA-IMATINIB | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2017 | EVICEL | Omrix Biopharmaceuticals Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2017 | BRIVLERA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2017 | APO-FAMCICLOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2017 | CIPRO XL | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2017 | INJECTABLE NALOXONE HYDROCHLORIDE | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2017 | CIPRO; CIPRO ORAL SUSPENSION | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2017 | GENVOYA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2017 | ADLYXINE | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 24, 2017 | HARVONI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| May 24, 2017 | OCALIVA | Intercept Pharmaceuticals Inc | New Drug Submission (NDS) · Priority-NAS |
| May 24, 2017 | OXALIPLATIN INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 23, 2017 | DESCOVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 23, 2017 | AGRIFLU; AGRIFLU (MULTI DOSE VIAL) | Seqirus Uk Limited | New Drug Submission (NDS) · Admin |
| May 23, 2017 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | New Drug Submission (NDS) · Admin |
| May 19, 2017 | OPTIRAY 240; OPTIRAY 240 ULTRAJECT; OPTIRAY 300; OPTIRAY 300 ULTRAJECT; OPTIRAY 320; OPTIRAY 320 ULTRAJECT; OPTIRAY 350; OPTIRAY 350 ULTRAJECT | Liebel-Flarsheim Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2017 | PROHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2017 | MULTIHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2017 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2017 | MITOXANTRONE INJECTION USP | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 19, 2017 | T-LO; TIMOLOL MALEATE-EX | Sandoz Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| May 19, 2017 | SUBOXONE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2017 | RAN-OLANZAPINE IR; RAN-OLANZAPINE ODT | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 19, 2017 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2017 | MAGNEVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2017 | GADOVIST 1.0 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2017 | PRIMOVIST | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2017 | BYDUREON | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2017 | PMS-METHOTREXATE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| May 18, 2017 | KINERET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2017 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | Pfizer Canada Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 17, 2017 | INTELENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2017 | CYTOSAR | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| May 17, 2017 | KALYDECO | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2017 | VEMLIDY | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Other |
| May 17, 2017 | CEFEPIME FOR INJECTION, USP | Qilu Pharmaceutical Co. Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| May 17, 2017 | RAGWITEK | Alk-Abello Inc | New Drug Submission (NDS) · Admin |
| May 17, 2017 | GRASTEK | Alk-Abello Inc | New Drug Submission (NDS) · Admin |
| May 17, 2017 | ELOCTATE | Bioverativ Canada Inc | New Drug Submission (NDS) · Admin |
| May 17, 2017 | ALPROLIX | Bioverativ Canada Inc | New Drug Submission (NDS) · Admin |
| May 17, 2017 | P.G. 600 - 5D | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2017 | P.G. 600 | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2017 | CARBOPLATIN INJECTION BP | Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| May 16, 2017 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| May 16, 2017 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| May 16, 2017 | CEFASEPTIN 750 MG | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 16, 2017 | CEFASEPTIN 300 MG | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 16, 2017 | CEFASEPTIN 75 MG | Vetoquinol N A Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 16, 2017 | PYCEZE | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| May 16, 2017 | NEUPOGEN | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2017 | METHOTREXATE INJECTION USP | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2017 | APO-EMTRICITABINE-TENOFOVIR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 15, 2017 | APO-METHOTREXATE | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2017 | KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION | Mallinckrodt Rp Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2017 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 15, 2017 | ALTERMATE | Arivac Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 12, 2017 | INTRALIPID 10%; INTRALIPID 20%; INTRALIPID 30% | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2017 | ELTROXIN | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| May 12, 2017 | PANTOPRAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2017 | PMS-PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2017 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Priority |
| May 11, 2017 | PANTOPRAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2017 | OXYNEO | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2017 | GEMCITABINE INJECTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2017 | MYLAN-MIRTAZAPINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2017 | APO-PROPAFENONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2017 | SANDOZ PANTOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2017 | CNJ-016 | Emergent Biosolutions Canada Inc | New Drug Submission (NDS) · Admin |
| May 9, 2017 | BAT | Emergent Biosolutions Canada Inc | New Drug Submission (NDS) · Admin |
| May 9, 2017 | BOSENTAN | Actelion Pharmaceuticals Ltd | New Drug Submission (NDS) · Admin |
| May 9, 2017 | JAMP-RANITIDINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| May 9, 2017 | ACCEL-CANDESARTAN/HCTZ | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 9, 2017 | TEVA-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2017 | PRECEDEX | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2017 | AVELOX; AVELOX I.V. | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2017 | PRIORIX-TETRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 8, 2017 | APO-NORFLOX | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 8, 2017 | CAPRELSA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 8, 2017 | FASLODEX | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 8, 2017 | ACCEL-CANDESARTAN | Accel Pharma Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 8, 2017 | CINACALCET | Jubilant Generics Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 5, 2017 | TECHNIVIE | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2017 | APO-RISEDRONATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2017 | AMLODIPINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| May 5, 2017 | TARO-TESTOSTERONE GEL (2.5G/PACKET); TARO-TESTOSTERONE GEL (5G/PACKET) | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 5, 2017 | BUSULFAN FOR INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 5, 2017 | REVOLADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2017 | JAMP-SIMVASTATIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 4, 2017 | PLEGRIDY; PLEGRIDY (STARTER KIT) | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2017 | TOUJEO SOLOSTAR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2017 | RAN-GLICLAZIDE MR | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2017 | WAYMADE-NAPROXEN | Waymade Plc | New Drug Submission (NDS) · Admin |
| May 4, 2017 | WAYMADE-NAPROXEN SODIUM DS; WAYMADE-NAPROXEN SODIUM | Waymade Plc | New Drug Submission (NDS) · Admin |
| May 4, 2017 | ACARIZAX | Alk-Abello Inc | New Drug Submission (NDS) · Other |
| May 4, 2017 | COSMONAUT 52 | London Dairy Supply Ltd | Abbreviated New Drug Submission (ANDS) · Admin |
| May 3, 2017 | AZITHROMYCIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 3, 2017 | PANTOPRAZOLE SODIUM FOR INJECTION | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2017 | APO-MIRTAZAPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2017 | JAMP-ROSUVASTATIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| May 3, 2017 | DIPROSONE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2017 | DIPROSONE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2017 | RIVA-AMLODIPINE | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 2, 2017 | HUMALOG; HUMALOG 200 UNITS/ML; HUMALOG MIX25; HUMALOG MIX50 | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2017 | MYLAN-LANSOPRAZOLE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2017 | TEVA-LEVOFLOXACIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2017 | REVOLADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2017 | JAMP-OLMESARTAN HCTZ | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2017 | JAMP-OLMESARTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2017 | PMS-OLMESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2017 | MYLAN-PROPAFENONE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 1, 2017 | JAMP-RISEDRONATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 1, 2017 | QUINSAIR | Horizon Pharma Ireland Ltd | New Drug Submission (NDS) · Admin |
| May 1, 2017 | COATED DAILY LOW DOSE ASA 81 MG | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2017 | OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2017 | OLMESARTAN | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 1, 2017 | JAMP-OLMESARTAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| May 1, 2017 | JAMP-OLMESARTAN HCTZ | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| May 1, 2017 | PMS-OLMESARTAN | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 1, 2017 | ACTONEL; ACTONEL DR | Warner Chilcott Canada Co | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2017 | MEN'S ROGAINE FOAM 5% | Johnson & Johnson Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 1, 2017 | OZANEX (OZENOXACIN) | Ferrer Internacional Sa | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 1, 2017 | TEVA-OLMESARTAN/HCTZ | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | ACH-OLMESARTAN | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE | Jubilant Generics Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | OLMESARTAN | Jubilant Generics Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | AURO-OLMESARTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | SANDOZ OLMESARTAN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | MED-OLMESARTAN | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | APO-OLMESARTAN/HCTZ | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | APO-OLMESARTAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | ACT OLMESARTAN | Actavis Pharma Company | Abbreviated New Drug Submission (ANDS) · Other |
| May 1, 2017 | ACT OLMESARTAN HCT | Actavis Pharma Company | Abbreviated New Drug Submission (ANDS) · Other |
| April 28, 2017 | MYLAN-PANTOPRAZOLE T | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2017 | CCP-CITALOPRAM | CellChem Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2017 | KALYDECO | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2017 | BLINCYTO | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2017 | HAVRIX 1440 / HAVRIX 720 JR; HAVRIX 720 JUNIOR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2017 | METHOTREXATE INJECTION, USP | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2017 | TOBRADEX | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| April 26, 2017 | DOM-MIRTAZAPINE | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 26, 2017 | BUSCOPAN | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Admin |
| April 26, 2017 | TEVA-PAROXETINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2017 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2017 | OFEV | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2017 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10 | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 25, 2017 | AGRIFLU | Novartis Vaccines And Diagnostics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2017 | OXALIPLATIN INJECTION | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 24, 2017 | VETOLEXIN 300 MG; VETOLEXIN 75 MG; VETOLEXIN 750 MG | Vetoquinol N A Inc | New Drug Submission (NDS) · Other |
| April 21, 2017 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2017 | DEPAKENE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2017 | TEGRETOL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2017 | INSPIOLTO RESPIMAT | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2017 | CERDELGA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 21, 2017 | JEVTANA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2017 | ERIVEDGE | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2017 | TAXOTERE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2017 | TEVA-CARBAMAZEPINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2017 | BANZEL | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2017 | RAN-RABEPRAZOLE EC | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 20, 2017 | REDDY-PROGESTERONE | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| April 19, 2017 | SANDOZ LANSOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2017 | PMS-LANSOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2017 | ZOMETA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2017 | ORKAMBI | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| April 18, 2017 | PROPAFENONE | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| April 18, 2017 | VIMPAT | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2017 | NAPROXEN; NAPROXEN EC | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 18, 2017 | ARIXTRA; ARIXTRA (0.4ML SINGLE USE PRE-FILLED SYRINGE); ARIXTRA (0.6ML SINGLE USE PRE-FILLED SYRINGE); ARIXTRA (0.8ML SINGLE USE PRE-FILLED SYRINGE) | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| April 18, 2017 | CYCLOBENZAPRINE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 18, 2017 | XOFIGO | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2017 | APIDRA (10 ML VIAL); APIDRA (3ML CARTRIDGE); APIDRA (3ML OPTISET); APIDRA (3ML SOLOSTAR) | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 18, 2017 | CASPOFUNGIN FOR INJECTION | Mda Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 18, 2017 | CASPOFUNGIN POWDER FOR INJECTION | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 18, 2017 | MYLAN-ATAZANAVIR | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| April 18, 2017 | CASPOFUNGIN ACETATE FOR INJECTION | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| April 18, 2017 | TEVA-ATAZANAVIR | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 18, 2017 | CASPOFUNGIN ACETATE FOR INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 13, 2017 | ZYDELIG | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2017 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2017 | EURO-CHLORHEXIDINE ALCOHOL FREE | Euro-Pharm International Canada Inc. | New Drug Submission (NDS) · Admin |
| April 13, 2017 | ODAN-BENZYDAMINE | Odan Laboratories Ltd. | Abbreviated New Drug Submission (ANDS) · Other |
| April 13, 2017 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2017 | DARZALEX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| April 13, 2017 | HIZENTRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2017 | POLYFLEX | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2017 | ACT ETIDRONATE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2017 | ACT ETIDROCAL | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2017 | CYCLODX | Ciuss De L'estrie - Centre Hospitalier Universitaire De Sherbrooke | Abbreviated New Drug Submission (ANDS) · Other |
| April 12, 2017 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2017 | TECENTRIQ | Hoffmann-La Roche Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 12, 2017 | MOXIFLOXACIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| April 12, 2017 | ENBREL | Immunex Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2017 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2017 | POMALYST | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2017 | BENEFIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2017 | ACLASTA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2017 | PRV-SILDENAFIL | Pharmapar Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 11, 2017 | JAMP-TACROLIMUS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| April 11, 2017 | JAMP-TACROLIMUS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| April 11, 2017 | APO-TACROLIMUS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 11, 2017 | APO-TACROLIMUS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 10, 2017 | PHARMORUBICIN PFS | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| April 10, 2017 | DOLOREX | Intervet Canada Corp | Abbreviated New Drug Submission (ANDS) · Other |
| April 7, 2017 | ROCURONIUM BROMIDE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 7, 2017 | DOM-ONDANSETRON | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 7, 2017 | RAN-PANTOPRAZOLE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 6, 2017 | PEMETREXED | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2017 | RANITIDINE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2017 | CARBAGLU | Orphan Europe Sarl | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2017 | MEROPENEM FOR INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 6, 2017 | XYNTHA; XYNTHA SOLOFUSE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2017 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2017 | ERELZI (SYRINGE); ERELZI (SENSOREADY PEN) | Sandoz Canada Inc. | New Drug Submission (NDS) · Other |
| April 5, 2017 | DOMPERIDONE | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 5, 2017 | RAN-PREGABALIN | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2017 | EURO-CHLORHEXIDINE | Euro-Pharm International Canada Inc. | New Drug Submission (NDS) · Admin |
| April 5, 2017 | RAPAFLO | Allergan Pharma Co. | New Drug Submission (NDS) · Admin |
| April 5, 2017 | RAN-PANTOPRAZOLE | Ranbaxy Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2017 | MYLAN-BUPRENORPHINE/NALOXONE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2017 | VINORELBINE TARTRATE FOR INJECTION | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2017 | VECTIBIX | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2017 | UTROGESTAN | Besins Healthcare S A | New Drug Submission (NDS) · Other |
| April 3, 2017 | MULTIHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 3, 2017 | CILOXAN | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| April 3, 2017 | WAYMADE-KETOROLAC TROMETHAMINE | Waymade Plc | New Drug Submission (NDS) · Labelling Only |
| April 3, 2017 | DOBUTAMINE INJECTION USP | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Other |
| March 31, 2017 | METVIX | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2017 | PAMIDRONATE DISODIUM FOR INJECTION | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2017 | BONEFOS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2017 | PMS-PAMIDRONATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2017 | ACETYLCYSTEINE SOLUTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2017 | MAR-RIZATRIPTAN ODT | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 31, 2017 | BERINERT 1500; BERINERT 500 | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2017 | PENTAMIDINE ISETIONATE FOR INJECTION, BP | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2017 | ZEULIDE DEPOT | Pendopharm Division Of De Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2017 | DOM-RISEDRONATE | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2017 | CLASTEON | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2017 | TARCEVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2017 | VASOTEC | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2017 | TEPADINA | Adienne Sa | New Drug Submission (NDS) · Other |
| March 28, 2017 | GELNIQUE | Allergan Pharma Co. | Supplement to a New Drug Submission (SNDS) · Other |
| March 28, 2017 | MED-CLINDAMYCIN | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 27, 2017 | NARCAN NASAL SPRAY | Adapt Pharma Operations Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2017 | JUXTAPID | Aegerion Pharmaceuticals Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2017 | PMS-NIFEDIPINE ER | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 27, 2017 | APO-SALVENT CFC FREE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 27, 2017 | TRAZODONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 27, 2017 | CYCLOSPRAY | Eurovet Animal Health B V | New Drug Submission (NDS) · Other |
| March 24, 2017 | DOM-AMLODIPINE | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 24, 2017 | VIGAMOX | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 24, 2017 | IBUPROFEN+METHOCARBAMOL CAPLETS | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 24, 2017 | MEMANTINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 24, 2017 | SANDOZ MORPHINE SR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2017 | MAR-GABAPENTIN TABS | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2017 | SIGNIFOR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2017 | ALOMIDE | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 23, 2017 | ACT ESOMEPRAZOLE | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2017 | AZARGA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 22, 2017 | MINT-ITRACONAZOLE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 21, 2017 | CELLCEPT I.V. | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 21, 2017 | ZANTAC; ZANTAC MAXIMUM STRENGTH NON-PRESCRIPTION | Sanofi Consumer Health Inc Sanofi Sante Grand Public Inc | New Drug Submission (NDS) · Admin |
| March 21, 2017 | RAPIVAB | Seqirus Uk Limited | New Drug Submission (NDS) · Admin |
| March 21, 2017 | ARICEPT | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 20, 2017 | CLÉO -35 | Altius Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 17, 2017 | PAZEO | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 17, 2017 | FLAREX | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 17, 2017 | TILDREN | Bimeda-MTC Animal Health Inc. | New Drug Submission (NDS) · Admin |
| March 17, 2017 | DOM-FINASTERIDE | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 17, 2017 | INVEGA SUSTENNA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2017 | CARNITOR | Sigma-Tau Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2017 | INFLUVAC | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2017 | PANTOPRAZOLE MAGNESIUM | Altius Healthcare Inc | New Drug Submission (NDS) · Admin |
| March 16, 2017 | PORTRAZZA | Eli Lilly Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 16, 2017 | MAR-ALLOPURINOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 16, 2017 | DUREZOL | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 15, 2017 | PRIMAQUINE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2017 | MINT-CLONIDINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2017 | SANDOZ EZETIMIBE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2017 | TRANEXAMIC ACID INJECTION BP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2017 | MEROPENEM FOR INJECTION USP | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2017 | TARO-TESTOSTERONE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2017 | TEVA-CYCLOSPORINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| March 14, 2017 | BOOSTRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2017 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2017 | ENBREL | Immunex Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2017 | IZBA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 13, 2017 | PMS-OMEPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 13, 2017 | PDP-AMANTADINE HYDROCHLORIDE CAPSULES; PDP-AMANTADINE HYDROCHLORIDE SYRUP | Pendopharm Division Of De Pharmascience Inc | New Drug Submission (NDS) · Admin |
| March 13, 2017 | CEFTIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 13, 2017 | BRINAVESS | Cardiome Uk Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 13, 2017 | SANDOZ VENLAFAXINE XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 13, 2017 | VECTIBIX | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2017 | KETAMINE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 10, 2017 | AURO-MIRTAZAPINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 10, 2017 | ONDANSETRON INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 10, 2017 | VPI-ETHACRYNATE SODIUM | Vpi Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| March 10, 2017 | CIMZIA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2017 | KADCYLA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2017 | LINEZOLID INJECTION | Mda Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 9, 2017 | STR-DULOXETINE | Star-Pharma Pan-America Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 9, 2017 | CLOTRIMAZOLE EXTERNAL CREAM REFILL | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2017 | BIO-FLUCONAZOLE | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| March 9, 2017 | ACT OXYCODONE CR | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2017 | MIDAZOLAM INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2017 | OSTEOVISION | Centre For Probe Development And Commercialization | Abbreviated New Drug Submission (ANDS) · Other |
| March 9, 2017 | FLUDEOXYGLUCOSE (F-18) | Lawson Health Research Institute | Abbreviated New Drug Submission (ANDS) · Other |
| March 9, 2017 | APO-ERLOTINIB | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2017 | BETOPTIC S | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| March 8, 2017 | ENTERIC COATED ASA DAILY LOW DOSE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2017 | YASMIN 21; YASMIN 28 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2017 | REVOLADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2017 | LUVOX | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2017 | METHOTREXATE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 6, 2017 | HALOPERIDOL LA | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2017 | TEVA-AZITHROMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2017 | SANDOZ LEVETIRACETAM | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 3, 2017 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2017 | PREZISTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2017 | ANTIZOL | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2017 | TRISENOX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2017 | NUCYNTA EXTENDED-RELEASE | Endo Ventures Ltd | New Drug Submission (NDS) · Labelling Only |
| March 3, 2017 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2017 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2017 | FLUVIRAL | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2017 | BOTOX | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2017 | SPECTRAMAST LC | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2017 | NEVANAC | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 28, 2017 | SANDOZ MIRTAZAPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 28, 2017 | CEFAZOLIN FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 28, 2017 | VIMPAT | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2017 | LACTIFENCE | DeLaval, Inc. | New Drug Submission (NDS) · Other |
| February 27, 2017 | DOM-RISEDRONATE | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 27, 2017 | ENTRESTO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2017 | ONCASPAR | Baxalta Canada Corporation | New Drug Submission (NDS) · Other |
| February 24, 2017 | IMURAN | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| February 24, 2017 | MAR-CANDESARTAN / HCTZ | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 24, 2017 | ORENCIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2017 | IBRANCE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2017 | ALKERAN | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| February 23, 2017 | SIMBRINZA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 23, 2017 | GPC-LINEZOLID INJECTION | Generic Partners (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2017 | MEROPENEM FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2017 | AURO-METFORMIN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 22, 2017 | NEURACEQ | Isologic Innovative Radiopharmaceuticals Ltd. | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 21, 2017 | CHAMPIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2017 | ELOXATIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2017 | NAROPIN | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 20, 2017 | BASAGLAR; BASAGLAR (KWIKPEN) | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2017 | TECHNIVIE | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2017 | ACT PEMETREXED | Actavis Pharma Company | Abbreviated New Drug Submission (ANDS) · Other |
| February 17, 2017 | MOTRIMAX 12 HOUR | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2017 | ARNUITY ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2017 | BREO ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2017 | OLESTYR | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| February 17, 2017 | CIPRODEX | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 17, 2017 | ANORO ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2017 | MINT-INDOMETHACIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 16, 2017 | VYVANSE | Shire Pharma Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2017 | REXULTI | Otsuka Pharmaceutical Co Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 16, 2017 | OXYTROL | Allergan Pharma Co. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2017 | CELLCEPT; CELLCEPT IV | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2017 | CLINDAMYCIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2017 | COXISTAC 12% GRANULAR | Phibro Animal Health Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2017 | NAT-IMATINIB | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2017 | IPG-QUETIAPINE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2017 | PMS-EPIRUBICIN | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| February 16, 2017 | AZOPT | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 16, 2017 | PMS-CYTARABINE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| February 16, 2017 | CUVITRU | Baxalta Canada Corporation | New Drug Submission (NDS) · Other |
| February 16, 2017 | TRAVATAN Z | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 16, 2017 | RIVA-LEVOTHYROXINE FOR INJECTION | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 15, 2017 | MITOXANTRONE INJECTION USP | Hospira Healthcare Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 13, 2017 | HARVONI | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2017 | REVOLUTION | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2017 | JEVTANA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 13, 2017 | CANDESARTAN | Jubilant Generics Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 13, 2017 | NUCYNTA IR | Endo Ventures Ltd | New Drug Submission (NDS) · Labelling Only |
| February 13, 2017 | HOLKIRA PAK | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2017 | LUPRON DEPOT | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2017 | ILEVRO | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 10, 2017 | MYLAN-ESOMEPRAZOLE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| February 10, 2017 | SANDOZ SUMATRIPTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 10, 2017 | FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 10, 2017 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2017 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2017 | ODEFSEY | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Other |
| February 10, 2017 | FLUZONE HIGH-DOSE | Sanofi Pasteur Limited | New Drug Submission (NDS) · Admin |
| February 10, 2017 | FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | New Drug Submission (NDS) · Admin |
| February 10, 2017 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2017 | BASAGLAR (KWIKPEN) | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2017 | REPLAGAL | Shire Human Genetic Therapies Inc | New Drug Submission (NDS) · Other |
| February 9, 2017 | APO-ASA LD | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| February 9, 2017 | RITUXAN; RITUXAN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2017 | PROLENSA | Bausch & Lomb Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2017 | OTIZOLE | Brite Ridge Pharmaceuticals | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2017 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | Mylan Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Other |
| February 7, 2017 | ZEVTERA | Basilea Pharmaceutica International Ag | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2017 | TIAZAC XC | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2017 | SANDOZ GLICLAZIDE MR | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| February 7, 2017 | MINT-KETOROLAC | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 7, 2017 | ONDANSETRON INJECTION BP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 7, 2017 | PANOLOG CREAM | Elanco Canada Limited | New Drug Submission (NDS) · Admin |
| February 6, 2017 | MYLAN-FENTANYL MATRIX PATCH | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 6, 2017 | GD-DESVENLAFAXINE | Genmed A Division Of Pfizer Canada Ulc | New Drug Submission (NDS) · Admin |
| February 3, 2017 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2017 | RIVA-RANITIDINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 3, 2017 | TESTIM 1% | Paladin Labs Inc | New Drug Submission (NDS) · Admin |
| February 3, 2017 | IPG-ATENOLOL | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 3, 2017 | IPG-ATENOLOL | Marcan Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| February 3, 2017 | FUROSEMIDE INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 3, 2017 | TRIESENCE | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 2, 2017 | PMS-CELECOXIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 2, 2017 | PATANOL | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 2, 2017 | PATADAY | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 1, 2017 | SANDOSTATIN LAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2017 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2017 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2017 | AURO-MIRTAZAPINE OD | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 1, 2017 | DUOTRAV PQ | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · Admin |
| February 1, 2017 | KETOROLAC TROMETHAMINE INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 31, 2017 | HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 31, 2017 | HYDROMORPHONE HYDROCHLORIDE INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 31, 2017 | TILMICOSIN 200 | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| January 30, 2017 | APO-CLOBAZAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 30, 2017 | SANDOZ ESOMEPRAZOLE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 30, 2017 | GPC-GLICLAZIDE MR | Generic Partners (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 30, 2017 | TORRENT-MOXIFLOXACIN | Torrent Pharmaceuticals Limited | Abbreviated New Drug Submission (ANDS) · Other |
| January 27, 2017 | PRISTIQ | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2017 | ALLEGRA-D | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2017 | DILANTIN INFATABS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2017 | PERJETA; PERJETA-HERCEPTIN COMBO PACK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2017 | EVRA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2017 | HERCEPTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2017 | LINXMED-SP | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 26, 2017 | NERISONE | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2017 | VANCOCIN | Merus Labs International Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2017 | VIBERZI | Allergan Pharma Co. | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 26, 2017 | APO-PHENYTOIN SODIUM | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 25, 2017 | ACH-ATORVASTATIN CALCIUM | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 24, 2017 | ZELBORAF | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2017 | LORAZEPAM INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 23, 2017 | AIROMIR | Valeant Canada Lp Valeant Canada S.E.C. | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2017 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2017 | GD-AZITHROMYCIN | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 23, 2017 | AMIODARONE HYDROCHLORIDE INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 20, 2017 | PREVACID; PREVACID FASTAB | Takeda Pharmaceuticals America Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2017 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2017 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2017 | BAR-HYDROMORPHONE HCL | Bard Pharmaceuticals (1990) Inc | New Drug Submission (NDS) · Labelling Only |
| January 20, 2017 | GLN-EZETIMIBE | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 20, 2017 | DAXAS | Astrazeneca Canada Inc | New Drug Submission (NDS) · Labelling Only |
| January 20, 2017 | OMNARIS | Astrazeneca Canada Inc | New Drug Submission (NDS) · Labelling Only |
| January 20, 2017 | ALVESCO | Astrazeneca Canada Inc | New Drug Submission (NDS) · Labelling Only |
| January 20, 2017 | TEVA-GLATIRAMER ACETATE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Admin |
| January 20, 2017 | ALLOPURINOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2017 | FRAXIPARINE (0.2ML PREFILLED SYRINGE); FRAXIPARINE (0.3ML PREFILLED SYRINGE); FRAXIPARINE (0.4ML PREFILLED SYRINGE); FRAXIPARINE (0.6ML PREFILLED SYRINGE); FRAXIPARINE (1 ML PREFILLED SYRINGE); FRAXIPARINE FORTE (0.6ML PREFILLED SYRINGE); FRAXIPARINE FORTE (0.8ML PREFILLED SYRINGE); FRAXIPARINE FORTE (1 ML PREFILLED SYRINGE) | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| January 20, 2017 | KADCYLA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2017 | ZYLOPRIM | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2017 | SUROLAN | Elanco Division Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2017 | ONGLYZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2017 | KOMBOGLYZE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2017 | EZETIMIBE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 17, 2017 | RIVA-RISEDRONATE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 17, 2017 | PMS-MIRTAZAPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2017 | LEUKERAN | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| January 17, 2017 | ARZERRA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2017 | LIXIANA | Servier Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| January 17, 2017 | TOBI PODHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2017 | INVOKANA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2017 | GLATECT | Pharmascience Inc. | New Drug Submission (NDS) · Other |
| January 17, 2017 | PLANATE | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| January 16, 2017 | MEMANTINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 16, 2017 | MYLERAN | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| January 16, 2017 | ROCURONIUM BROMIDE INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 16, 2017 | ALLERGY RELIEF NASAL SPRAY | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 13, 2017 | NALOXONE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2017 | HYDROMORPHONE HP 10; HYDROMORPHONE HP 20; HYDROMORPHONE HP 50; HYDROMORPHONE HP FORTE; HYDROMORPHONE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2017 | APO-METFORMIN ER | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 13, 2017 | PMS-AMLODIPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2017 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2017 | METHOTREXATE TABLETS, USP | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2017 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 13, 2017 | LUTALYSE HC | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2017 | SEPTRA INJECTION | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| January 12, 2017 | FRAGMIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2017 | APO-METHOTREXATE | Hospira Healthcare Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2017 | ACT RIVASTIGMINE PATCH 10; ACT RIVASTIGMINE PATCH 5 | Actavis Pharma Company | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2017 | KEVZARA | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 12, 2017 | ACT RIVASTIGMINE PATCH 10; ACT RIVASTIGMINE PATCH 5 | Actavis Pharma Company | Abbreviated New Drug Submission (ANDS) · Other |
| January 11, 2017 | 24HR NASAL ALLERGY RELIEF | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| January 11, 2017 | IPG-CANDESARTAN+HCT | International Pharmaceutical Generics Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2017 | GEMCITABINE FOR INJECTION | Teligent Ou | Abbreviated New Drug Submission (ANDS) · Admin |
| January 11, 2017 | LANVIS | Aspen Pharmacare Canada Inc. | New Drug Submission (NDS) · Admin |
| January 10, 2017 | JADENU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 10, 2017 | ONDANSETRON INJECTION USP; ONDANSETRON INJECTION USP (PRESERVATIVE-FREE) | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2017 | TEVA-CLOBAZAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 9, 2017 | DEXIRON | Luitpold Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2017 | PMS-ONDANSETRON | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 9, 2017 | AVASTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2017 | CARDIOLITE | Lantheus Mi Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 9, 2017 | EPTIFIBATIDE INJECTION | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| January 9, 2017 | SEHCAT | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 6, 2017 | ADVAIR; ADVAIR DISKUS | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 6, 2017 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 6, 2017 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| January 6, 2017 | FIASP | Novo Nordisk Canada Inc | New Drug Submission (NDS) · Other |
| January 6, 2017 | IMOVAX POLIO | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2017 | MICTORYL; MICTORYL PEDIATRIC | Duchesnay Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 5, 2017 | ULORIC | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2017 | FINASTERIDE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 5, 2017 | RAPIVAB | Biocryst Pharmaceuticals Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 4, 2017 | CITALOPRAM | CellChem Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 4, 2017 | RUPALL | Pediapharm Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2017 | PRO-VALACYCLOVIR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 4, 2017 | FORADIL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2017 | ONBREZ BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2017 | LETROZOLE | CellChem Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2017 | RAN-ZOPICLONE | Ranbaxy Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 3, 2017 | DYSPORT AESTHETIC | Ipsen Biopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2017 | DYSPORT THERAPEUTIC | Ipsen Biopharm Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 3, 2017 | INOMAX | Ino Therapeutics | Supplement to a New Drug Submission (SNDS) · Other |